CH584724A5 - - Google Patents

Info

Publication number
CH584724A5
CH584724A5 CH1075067A CH1069375A CH584724A5 CH 584724 A5 CH584724 A5 CH 584724A5 CH 1075067 A CH1075067 A CH 1075067A CH 1069375 A CH1069375 A CH 1069375A CH 584724 A5 CH584724 A5 CH 584724A5
Authority
CH
Switzerland
Application number
CH1075067A
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH584724A5 publication Critical patent/CH584724A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1075067A 1966-07-29 1975-08-15 CH584724A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3427566 1966-07-29
GB23066/67A GB1202521A (en) 1966-07-29 1966-07-29 01beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
CH584724A5 true CH584724A5 (en) 1977-02-15

Family

ID=26256295

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1075067A CH580644A5 (en) 1966-07-29 1967-07-28
CH1075067A CH584724A5 (en) 1966-07-29 1975-08-15

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1075067A CH580644A5 (en) 1966-07-29 1967-07-28

Country Status (12)

Country Link
JP (2) JPS5021469B1 (en)
AT (2) AT301766B (en)
BE (1) BE702023A (en)
CH (2) CH580644A5 (en)
DE (1) DE1668124B2 (en)
DK (2) DK129004B (en)
FR (2) FR1565340A (en)
GB (1) GB1202521A (en)
IL (1) IL28411A (en)
NL (1) NL6710459A (en)
PL (1) PL79253B1 (en)
SE (2) SE349025B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1289521A (en) * 1969-01-23 1972-09-20
GB1313659A (en) * 1969-07-25 1973-04-18 Glaxo Lab Ltd 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds
JPS5090183A (en) * 1973-12-14 1975-07-19
JPS5090184A (en) * 1973-12-14 1975-07-19

Also Published As

Publication number Publication date
NL6710459A (en) 1968-01-30
DK131295C (en) 1975-11-17
PL79253B1 (en) 1975-06-30
GB1202521A (en) 1970-08-19
DK129004B (en) 1974-08-05
FR1565340A (en) 1969-05-02
AT301766B (en) 1972-09-25
JPS5224013B1 (en) 1977-06-28
SE350488B (en) 1972-10-30
IL28411A (en) 1972-07-26
FR7812M (en) 1970-05-20
DK131295B (en) 1975-06-23
JPS5021469B1 (en) 1975-07-23
AT311564B (en) 1973-11-26
DE1668124B2 (en) 1976-10-07
DE1668124A1 (en) 1971-05-06
SE349025B (en) 1972-09-18
CH580644A5 (en) 1976-10-15
BE702023A (en) 1968-01-29

Similar Documents

Publication Publication Date Title
DK131295C (en)
AT281852B (en)
AU5917865A (en)
AU424443B2 (en)
AU428063B2 (en)
AU433222B2 (en)
AU421822B2 (en)
AU417216B2 (en)
AU1111066A (en)
AU612166A (en)
AU218666A (en)
AU6703465A (en)
AU1144366A (en)
AU5895065A (en)
BE694725A (en)
AU411645B2 (en)
AU1027866A (en)
AU415780B2 (en)
AU433620A (en)
BE692286A (en)
AU6852465A (en)
BE674713A (en)
BE694311A (en)
AU855865A (en)
AU92366A (en)

Legal Events

Date Code Title Description
PL Patent ceased